Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentric, Randomized, Double-Blind, Comparative, Prospective, Placebo-controlled, Phase-II/III Clinical Trial (ACCROS-III)

NCT05886829 is registered in ClinicalTrials.gov with Dr. Ferrer BioPharma as lead sponsor.

NCT NCT05886829
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05886829 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentric, Randomized, Double-Blind, Comparative, Prospective, Placebo-controlled, Phase-II/III Clinical Trial (ACCROS-III)
Lead sponsor
Dr. Ferrer BioPharma
Phase
Phase 2/3
Overall status
Completed
Start date
July 27, 2022
Completion date
February 1, 2023
Enrollment
157 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus disease 2019, coronavirus infections, covid-19, covid-19 pandemic, symptoms and signs